245 related articles for article (PubMed ID: 30365189)
1. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
[TBL] [Abstract][Full Text] [Related]
2. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
Leng Y; Abdullah A; Wendt MK; Calve S
Matrix Biol; 2019 May; 78-79():236-254. PubMed ID: 30130585
[TBL] [Abstract][Full Text] [Related]
4. Emodin regulates cell cycle of non-small lung cancer (NSCLC) cells through hyaluronan synthase 2 (HA2)-HA-CD44/receptor for hyaluronic acid-mediated motility (RHAMM) interaction-dependent signaling pathway.
Li M; Jin S; Cao Y; Xu J; Zhu S; Li Z
Cancer Cell Int; 2021 Jan; 21(1):19. PubMed ID: 33407495
[TBL] [Abstract][Full Text] [Related]
5. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.
Foley JP; Lam D; Jiang H; Liao J; Cheong N; McDevitt TM; Zaman A; Wright JR; Savani RC
J Biol Chem; 2012 Oct; 287(44):37406-19. PubMed ID: 22948158
[TBL] [Abstract][Full Text] [Related]
7. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
Matou-Nasri S; Gaffney J; Kumar S; Slevin M
Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
[TBL] [Abstract][Full Text] [Related]
8. RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR.
Hatano H; Shigeishi H; Kudo Y; Higashikawa K; Tobiume K; Takata T; Kamata N
Lab Invest; 2011 Mar; 91(3):379-91. PubMed ID: 20956971
[TBL] [Abstract][Full Text] [Related]
9. RHAMM expression tunes the response of breast cancer cell lines to hyaluronan.
Carvalho AM; Soares da Costa D; Reis RL; Pashkuleva I
Acta Biomater; 2022 Jul; 146():187-196. PubMed ID: 35577044
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.
Twarock S; Tammi MI; Savani RC; Fischer JW
J Biol Chem; 2010 Jul; 285(30):23276-84. PubMed ID: 20463012
[TBL] [Abstract][Full Text] [Related]
11. The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury.
Cui Z; Liao J; Cheong N; Longoria C; Cao G; DeLisser HM; Savani RC
Matrix Biol; 2019 May; 78-79():255-271. PubMed ID: 30098420
[TBL] [Abstract][Full Text] [Related]
12. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines.
Teder P; Bergh J; Heldin P
Cancer Res; 1995 Sep; 55(17):3908-14. PubMed ID: 7543820
[TBL] [Abstract][Full Text] [Related]
13. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis.
Savani RC; Cao G; Pooler PM; Zaman A; Zhou Z; DeLisser HM
J Biol Chem; 2001 Sep; 276(39):36770-8. PubMed ID: 11448954
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation.
Gouëffic Y; Guilluy C; Guérin P; Patra P; Pacaud P; Loirand G
Cardiovasc Res; 2006 Nov; 72(2):339-48. PubMed ID: 16934786
[TBL] [Abstract][Full Text] [Related]
15. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
[TBL] [Abstract][Full Text] [Related]
16. CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).
Oldenburg D; Ru Y; Weinhaus B; Cash S; Theodorescu D; Guin S
BMC Cancer; 2016 Sep; 16(1):713. PubMed ID: 27595989
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronate receptors mediating glioma cell migration and proliferation.
Akiyama Y; Jung S; Salhia B; Lee S; Hubbard S; Taylor M; Mainprize T; Akaishi K; van Furth W; Rutka JT
J Neurooncol; 2001 Jun; 53(2):115-27. PubMed ID: 11716065
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance.
Coleman KL; Chiaramonti M; Haddad B; Ranzenberger R; Henning H; Al Khashali H; Ray R; Darweesh B; Guthrie J; Heyl D; Evans HG
Cells; 2023 Jan; 12(3):. PubMed ID: 36766747
[TBL] [Abstract][Full Text] [Related]
19. Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation.
Carvalho AM; Soares da Costa D; Paulo PMR; Reis RL; Pashkuleva I
Acta Biomater; 2021 Jan; 119():114-124. PubMed ID: 33091625
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44.
Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM
Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
